|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | C07D 253/06 | (2006.01) |
| A61K 31/53 | (2006.01) | ||
| C07D 253/075 | (2006.01) | ||
| G01N 30/00 | (2006.01) | ||
| G01N 30/02 | (2006.01) | ||
| G01N 30/04 | (2006.01) | ||
| G01N 30/86 | (2006.01) | ||
| G01N 30/88 | (2006.01) | ||
| G01N 30/90 | (2006.01) | ||
| G01N 33/00 | (2006.01) | ||
| G01N 33/15 | (2006.01) |
| (11) | Number of the document | 0963980 |
| (13) | Kind of document | T |
| (96) | European patent application number | 99200695.7 |
| Date of filing the European patent application | 1999-03-10 | |
| (97) | Date of publication of the European application | 1999-12-15 |
| (45) | Date of publication and mention of the grant of the patent | 2002-06-05 |
| (46) | Date of publication of the claims translation |
| (30) | Number | Date | Country code |
| 9812413 | 1998-06-10 | GB |
| (72) |
Edmeades, Lorraine Mary, GB
Griffith-Skinner, Nigel Arthur, GB
Hill, Derek Anthony, GB
Hill, Graham Thornton, GB
Packham, Terrence William, GB
|
| (73) |
THE WELLCOME FOUNDATION LIMITED,
Glaxo Wellcome House, Berkeley Avenue Greenford,, Middlesex UB6 0NN,
GB
|
| (54) | 1,2,4-Triazine derivative, its preparation and its use as reference marker for testing purity and stability of "lamotrigine" |
| 1,2,4-Triazine derivative, its preparation and its use as reference marker for testing purity and stability of "lamotrigine" |